Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Pfizer scientists describe novel PPARgamma ligands and their use

Nov. 10, 2003

Novartis presents new PTP1B inhibitors in a recent patent

Nov. 10, 2003

Spanish researchers prepare and test novel cannabinoid CB1 antagonists

Nov. 10, 2003

Positive animal data reported for Alvair

Nov. 7, 2003

Merck scientists discover novel DPP-IV inhibitors for type 2 diabetes and other uses

Nov. 7, 2003

New European approval for Bondronat

Nov. 6, 2003

Roll-out of Forsteo across E.U.

Nov. 6, 2003

Phase II results for HE-2200 fail to confirm earlier findings of cholesterol reduction

Nov. 6, 2003

Kos and Takeda to copromote Niaspan and Advicor in U.S.

Nov. 6, 2003

BMP2 gene and variants linked to osteoporosis

Nov. 6, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...